Furthermore, since this increase is prevented by the blockade of AT1 receptors, these results suggest an important role for the rennin-angiotensin-aldosterone system (RAAS) in the pathophysiology of HT related to OSA (Foster et al., 2010). The gene discussed is AGTR1; the disease is hematocrit.